Fragrance OEM vs. In-House Formulation: A Practical Decision Guide for Emerging Brands

Quick answer: Most emerging fragrance brands should start with an OEM. This reduces laboratory costs, hiring pressure, raw-material inventory, production risk, and the time needed to launch the first product. In-house formulation becomes practical when the brand develops products throughout the year, needs direct access to formulas, has qualified technical staff, and can fund the operation for several years. A hybrid model is often the best long-term choice: the brand controls fragrance development while an experienced manufacturer handles commercial blending, filling, packaging, and batch production.

This guide mainly covers eau de parfum, eau de toilette, extrait de parfum, and other alcohol-based fine fragrances. Candles, diffusers, body care, hair mists, and solid perfumes require different bases, safety reviews, packaging tests, and production controls.

XUELEI provides fragrance development, packaging coordination, manufacturing, quality control, and documentation support through its fragrance OEM and ODM services. The decision is not simply whether to outsource. It is about which capabilities the brand should control and which activities can be handled more efficiently by a manufacturing partner.

OEM and In-House Formulation

A fragrance OEM develops, manufactures, or coordinates the production of fragrance products for another brand. Depending on the project, the service may include:

• Fragrance development
• Raw-material sourcing
• Alcohol blending
• Maturation and filtration
• Bottle and pump sourcing
• Filling and pump fitting
• Label and carton assembly
• Finished-product testing
• Batch records and export documents

Not every OEM completes all these steps internally. One company may develop the fragrance concentrate, while another company blends and fills the finished perfume. Before paying a development fee or deposit, the brand should confirm who controls each part of the project.

In-house formulation means the brand employs or directly manages the people who create and revise the fragrance formula. Commercial manufacturing may still be outsourced.

Owning a formula and owning a factory are separate decisions. A brand can build strong formulation knowledge without investing in alcohol storage, maturation tanks, filling lines, packaging equipment, and finished-goods warehousing.

Several supplier terms are often confused:

• Private label: The brand selects an existing supplier formula and changes the name, packaging, concentration, or limited product details.
• ODM: The supplier provides an existing product platform, formula, design, or packaging solution that can be adapted.
• Custom OEM: The supplier develops a product from the brand's brief. “Custom” does not automatically provide formula ownership or exclusivity.
• Fragrance house: The company develops and supplies fragrance concentrate but may not fill the finished perfume.
• Contract manufacturer: The factory produces a product using an approved formula supplied by the brand or another fragrance developer.
• Turnkey manufacturer: The supplier coordinates most stages from product concept to finished shipment.

What the Brand Should Control

A brand does not need to perform every task. It should control the decisions that affect the customer, product identity, acceptable quality, legal risk, and long-term business independence.

For example, an OEM may explain that a material increases cost or creates a color problem. The brand should decide whether to change the formula, accept the higher cost, or adjust the product position.

When a formula, material, supplier, process, or packaging part changes, the project should state:

• Why the change is needed
• How it may affect scent, color, stability, cost, and labeling
• Which documents must be updated
• Which tests must be repeated
• Who gives final written approval

Outsourcing production does not remove the need for specifications and records. The brand should still know which formula version, raw-material batches, packaging parts, and tests were used for each finished batch.

Why Emerging Brands Choose OEM

The main benefit of an OEM is access to an existing technical and production system. A capable supplier may already have perfumers, evaluators, laboratory staff, production workers, approved raw-material sources, filling equipment, packaging resources, and batch-control procedures.

Lower fixed costs. A working fragrance laboratory may need ventilation, fire-safe storage, precision balances, controlled raw-material storage, formula software, safety procedures, insurance, trained staff, and external testing. Hiring one perfumer does not provide all these functions.

Faster first project. An OEM is often faster for a brand that has no laboratory or production team. An established in-house team may be faster for daily revisions, but building that team takes time and money.

A commercial fragrance project commonly includes:

1. Brief approval
2. First fragrance samples
3. Sample evaluation
4. Formula revisions
5. Final fragrance approval
6. Cost and document review
7. Packaging approval
8. Compatibility testing
9. Material purchasing
10. Pilot or scale-up production
11. Commercial production
12. Batch testing and release
13. Shipping

The following figures are practical planning ranges rather than guaranteed industry timelines:

Simple projects may be planned around two to four fragrance revision rounds. If the project passes five rounds while the customer, price, fragrance family, concentration, and product direction continue to change, the main problem is usually the brief rather than one small formula detail.

Each revision should focus on one to three clear issues. A promise such as “first sample in seven days” does not mean the finished product will be ready in seven days. Packaging, testing, material availability, and the production schedule may take longer than fragrance development.

XUELEI's perfume manufacturing process guide explains how formulation, testing, compounding, maturation, filling, and final release connect.

Easier sourcing. A fragrance formula may use dozens of materials. The manufacturer must control supplier identity, material grade, odor, purity, storage, shelf life, batch variation, and approved substitutes.

In an illustrative case, a formula may use only 50 grams of a material while the available supplier pack is 5 kilograms. The remaining material ties up cash and may require quality reassessment before it is used again.

The same material name does not always guarantee the same performance. Changes in supplier, origin, harvest, processing, purity, or storage can affect scent, color, solubility, stability, allergen calculations, and cost. XUELEI's guide to natural and synthetic fragrance materials explains why both material types require supplier checks and batch control.

Lower coordination workload. A full-service supplier may coordinate the fragrance concentrate, bottle, pump, cap, label, carton, filling, inspection, and shipment. This reduces the number of suppliers and purchase orders managed by a small team.

The disadvantage is concentrated risk. If one supplier controls the formula, packaging, production schedule, and documents, one delay can affect the whole launch. The brand should know which work is completed internally, which work is subcontracted, and who owns unused packaging or custom tools.

Safer demand testing. A new brand should not build a permanent laboratory based only on launch-month sales. Discounts, founder audiences, publicity, and wholesale pre-orders may create a temporary sales increase.

A stronger decision uses several sales and replenishment cycles and reviews:

• Sample-to-purchase conversion
• Full-price conversion
• Repeat purchase rate
• Return rate
• Gross margin after samples and returns
• Retailer reorder rate
• Time needed to sell the first batch
• Complaints by batch

OEM Risks to Check Before Signing

OEM reduces setup work, but it can create long-term dependence when the contract, formula rights, minimum quantities, and change procedures are unclear.

Formula rights. A custom fragrance is not automatically owned by the brand. The supplier may provide finished concentrate, ingredient information, an allergen declaration, and a formula code without providing the complete formula.

Four rights should be checked separately:

• Formula access: Can the brand receive or inspect the complete quantitative formula?
• Exclusivity: Can the supplier sell the same formula to another customer?
• Similarity restriction: Can the supplier make a small change and sell a very similar scent?
• Transfer rights: Can the brand give the formula to another qualified manufacturer?

A brand may have exclusivity without receiving the formula. It may also receive a written formula that another factory cannot reproduce because the formula contains a supplier-owned base, internal code, captive material, or unavailable ingredient.

A practical transfer package may need:

• Final formula and version number
• Raw-material names, suppliers, and grades
• Approved substitutes
• Mixing sequence
• Dilution instructions
• Maturation and filtration requirements
• Finished-product specification
• Approved reference sample
• Current safety and allergen information

Supplier exit risk. The agreement should state what the brand receives when the relationship ends. This may include current formula information, batch records, reference samples, unused packaging, tooling records, open-order status, and transfer support.

Slow revisions. External development becomes slow when feedback moves through sales staff, a project manager, a perfumer, a laboratory, and sample shipping.

Comments such as “make it more premium” are too vague. Useful comments describe a specific problem:

• The opening is too sharp during the first five minutes.
• The vanilla becomes too sweet after one hour.
• The citrus disappears too quickly.
• The dry-down feels too dry.
• Version B is closer, but the amber effect should be reduced.

Samples should use neutral codes, the same application method, written evaluation notes, and one final decision maker.

MOQ risk. The finished-product MOQ is only one number. Separate minimums may apply to:

• Fragrance concentrate
• Bottle
• Pump
• Cap and collar
• Label
• Carton
• Insert
• Custom printing or decoration

Consider an illustrative packaging case:

The unused 4,000 bottles do not become finished goods until the brand pays for fragrance concentrate, pumps, caps, filling, labels, cartons, assembly, and storage. If the packaging design changes, the loss may include the bottle, decoration, transport, storage, and tied-up cash.

These figures are examples, not standard industry minimums. Before placing an order, confirm who owns excess components, where they will be stored, whether storage is charged, how damaged stock is handled, and whether unused parts can be moved to another factory.

Unapproved changes. A material may become unavailable, restricted, inconsistent, or too expensive. The supplier should not replace it without an agreed change process.

1. Explain the reason for the proposed change.
2. Compare the old and new materials.
3. Review scent, cost, stability, and regulatory effects.
4. Prepare a revised sample.
5. Repeat the required tests.
6. Issue updated documents.
7. Obtain written approval.
8. Create a new formula version.
9. Identify the first production batch using the change.

Why Some Brands Build In-House Formulation

In-house formulation becomes useful when fragrance creation is part of the company's main advantage and the team has enough work throughout the year.

Possible benefits include:

• Faster daily revisions
• Direct formula-cost control
• Faster evaluation of substitute materials
• Better formula-version records
• Stronger internal fragrance knowledge
• Easier development of related products
• Better preparation for production transfer

Owning a formula does not guarantee an immediate factory transfer. The receiving manufacturer must still confirm access to every material, supplier and grade equivalence, mixing sequence, alcohol handling, maturation, filtration, scale-up behavior, and finished-product limits.

Faster experiments. An internal perfumer can prepare several controlled trials without waiting for external sample shipment. This is useful when the company runs several projects at once or frequently changes cost, materials, concentration, or product format.

Each commercial project should define:

• Target customer
• Target price
• Fragrance family
• Concentration
• Formula-cost ceiling
• Required and unwanted characteristics
• Planned review rounds
• Final decision maker
• Pause or cancellation conditions

Without these limits, faster sampling may create more unfinished trials rather than more finished products.

Stored knowledge. Formula versions, material suppliers, test results, packaging failures, consumer feedback, production deviations, and successful substitutions should be recorded in a searchable system. Useful knowledge should remain with the company rather than one employee.

Product extensions. A fragrance identity may be adapted for eau de parfum, eau de toilette, lotion, shower gel, candles, diffusers, hair mist, or solid perfume. The same formula should not be copied directly into every base.

The following ranges are common commercial planning references, not fixed legal definitions:

Actual concentration varies by formula, market, product concept, raw materials, and performance target. A fragrance at 18% is not automatically stronger or longer lasting than every fragrance at 15%. Evaporation, material structure, application amount, skin, climate, and storage also affect performance.

Alcohol, water, oil, wax, emulsions, surfactant systems, and diffuser solvents change how a fragrance dissolves, evaporates, and smells. Maintaining a similar scent usually requires formula adjustment, compatibility testing, and a new safety review.

XUELEI's perfume concentration guide explains why EDT, EDP, and extrait de parfum should not be treated as simple quality rankings.

Compare the Full Cost

The salary of one perfumer should not be compared directly with one OEM development fee. Both sides have additional costs.

Consider a hypothetical internal formulation operation costing $180,000 per year. This could include one perfumer, technical support, basic laboratory space, materials, software, routine external testing, and regulatory support. It does not represent a standard global cost and does not include a commercial filling line.

The calculation shows why laboratory use matters. A team producing hundreds of trials but completing only three useful commercial projects may be more expensive than an external development model.

A useful calculation is:

Annual internal formulation cost ÷ commercially useful projects = internal cost per useful project

Commercially useful work may include:

• New formulas launched
• Existing formulas successfully reformulated
• Approved cost-saving changes
• Completed product extensions
• Production problems solved
• Supplier transfers completed

Experimental samples should not be counted as completed projects unless they create a product, approved improvement, or solved technical problem.

Hiring and Formula Security

A creative perfumer is not automatically able to manage cost, scale-up, documents, suppliers, and production problems.

A technical hiring assessment should check whether the candidate can:

• Work within a cost target
• Control formula versions
• Handle discontinued materials
• Prepare production instructions
• Investigate batch differences
• Work with quality and regulatory teams

The company should also prepare for resignation, long-term absence, recruitment delays, and formula handover.

Formula files should not exist only on one employee's computer. A practical control system should include:

• One approved production formula
• A clear version number
• Separate draft and approved folders
• Restricted editing rights
• Automatic backups
• Approval records
• A list of files shared with external manufacturers
• Removal of obsolete versions
• Removal of access after role changes

A protected formula is still a business risk if no one else can understand it, source the materials, or reproduce the product.

Testing Before Commercial Release

A fragrance that smells good can still fail because of cloudiness, color change, sediment, leakage, poor spray performance, incorrect fill volume, damaged decoration, or batch inconsistency.

XUELEI's fragrance OEM quality-control guide explains why formula approval, packaging tests, batch records, and finished-product release must work as one system.

ISO 22716 provides guidelines for the production, control, storage, and shipment of cosmetic products. It covers manufacturing quality practices but does not replace product development, finished-product safety assessment, or market-specific legal review.^[1]

Formula screening. Early samples should be checked for scent direction, solubility, cloudiness, sediment, obvious color change, formula cost, and availability of important materials.

Package compatibility. Testing should use the intended commercial bottle, pump, gasket, collar, cap, coating, decoration, label, and carton. A laboratory bottle cannot show how the final pump, gasket, adhesive, or decoration will behave.

Common problems include:

• Pump blockage
• Gasket swelling
• Tube damage
• Collar corrosion
• Coating damage
• Label lifting
• Decoration peeling
• Leakage during storage or shipping

The cause may come from the fragrance formula, alcohol level, gasket material, pump, fitting pressure, coating, adhesive, assembly method, storage, or transport.

Stability testing. The final product may be observed under room temperature, elevated temperature, lower temperature, light exposure, and temperature cycling.

The following times are practical project-planning references, not universal pass criteria:

A four- or eight-week test cannot prove that a product will remain unchanged for two or three years. Accelerated testing can reveal risks but should not be treated as a simple replacement for real-time observation.

The tested sample should use the final formula, final concentration, and intended packaging.

Batch release. Commercial production should be compared with a written specification and an approved reference sample.

Release checks may include:

• Batch identity
• Formula version
• Appearance and odor
• Fill volume or weight
• Spray function
• Leakage
• Pump or crimp condition
• Packaging condition
• Batch coding
• Required production records

As an internal control example, multiple finished units can be selected and sprayed five to ten times each to check whether the spray is continuous, centered, and free from visible leakage. This is not a universal sampling rule. The actual inspection quantity and acceptance limit should be defined by the product specification and batch size.

Retention samples. A small project may keep two to six complete finished units from each commercial batch for later comparison and complaint investigation. Larger-volume, longer-selling, or multi-market products may need more samples. This is an internal planning example rather than a universal legal minimum.

Each retention sample should show:

• Product name
• Batch number
• Formula version
• Packaging version
• Production date
• Approval status

When a batch differs from the approved standard, affected stock should be isolated, shipment should stop where possible, records and retained samples should be reviewed, and the batch should be accepted, reworked, or rejected based on the investigation.

Compliance Responsibilities

Using an OEM does not automatically remove the legal duties of the brand, manufacturer, importer, distributor, or another responsible party. The applicable role depends on the market, label, product type, claims, import structure, and manufacturing location.

A supplier may provide documents, but the brand should confirm that they match the final formula, concentration, product category, target country, and current formula version.

Common documents include:

• Ingredient information
• Allergen declaration
• IFRA Certificate of Conformity
• Safety data sheet
• Finished-product specification
• Batch certificate
• Stability records
• Packaging test records

An IFRA Certificate of Conformity applies to a fragrance mixture for its intended product use. It does not replace a finished-product safety assessment or government approval. IFRA also explains that an individual raw material does not normally receive the same type of certificate.^[2]

United States. FDA generally does not approve cosmetic products or ingredients before sale, except for certain color additives. Companies remain responsible for marketing safe and properly labeled cosmetic products.^[3]

Under MoCRA, manufacturers and processors may have facility-registration duties, while the manufacturer, packer, or distributor whose name appears on the label may be the responsible person for product listing. Relevant exemptions and product conditions should be checked rather than assumed.^[4]

European Union. A cosmetic product placed on the EU market requires an EU-based Responsible Person. Before market placement, the Responsible Person must ensure that a safety assessment and Cosmetic Product Safety Report are completed, a Product Information File is maintained, and the required product notification is submitted. The Product Information File must be kept for ten years after the last batch is placed on the market.^[5]

Regulation (EU) 2023/1545 expanded individual fragrance-allergen labeling. The applicable declaration thresholds are generally 0.001% in leave-on products and 0.01% in rinse-off products. Products that do not meet the new requirements may be placed on the EU market until 31 July 2026, while products already placed on the market may continue to be made available until 31 July 2028.^[6]

Common compliance mistakes include:

• Using documents prepared for an earlier sample formula
• Using the wrong product category or concentration
• Failing to update documents after a material change
• Using allergen data that does not match the label
• Treating a fragrance SDS as a complete finished-product file
• Using one label in several markets without review
• Describing IFRA conformity as government approval

How to Check an OEM

A supplier should not be selected only because the first sample smells good. XUELEI's guide to choosing a private label perfume factory explains why formula control, production capacity, packaging, documents, and defect responsibility should be reviewed together.

A simple 100-point internal score can help compare suppliers. The figures below are suggested evaluation weights, not an industry certification system.

A high total score should not hide a serious failure. Missing material traceability, uncontrolled formula changes, no batch records, or no finished-product release standard should be treated as major risks even when the supplier performs well in other areas.

The quotation should separately show development, revisions, fragrance concentrate, filling, packaging, assembly, testing, storage, tooling, freight terms, payment schedule, and price-adjustment conditions.

A Practical Hybrid Route

Many brands do not need to choose one permanent model. Technical capability can be added in stages.

Start with an OEM. Use the first projects to learn how to write briefs, evaluate samples, review documents, approve packaging, inspect production, and collect sales data. Keep approved samples, cost records, current documents, and clear formula rights.

Add an evaluator. An evaluator or technical product manager may be more useful than a full internal perfumer when revision rounds are increasing, several suppliers must be compared, or no one is maintaining reference samples and technical files.

Build formulation capability. Consider an internal perfumer and laboratory when the company has stable project volume, multi-year funding, qualified technical leadership, suitable space, raw-material controls, safety procedures, and reliable production partners.

Keep production outsourced. The brand can control formula development while a qualified manufacturer manages commercial blending, filling, packaging, and batch release.

A production handover should include the approved formula, material specifications, suppliers, mixing sequence, maturation and filtration requirements, finished-product specification, packaging standard, reference sample, and change procedure.

Decision Table

Score each area from 1 to 5. A score of 1 favors OEM. A score of 5 favors in-house formulation.

A low score supports OEM development. A middle score usually supports a hybrid model. A high score supports further evaluation of an internal formulation team.

Before choosing in-house formulation, four conditions should still be met:

• A qualified technical leader is available.
• The operation can be funded for several years.
• There is enough regular development work.
• The company can manage safety, documents, materials, and formula versions.

A high score does not prove that an internal laboratory will be profitable. It must still be checked against realistic project volume and the full annual cost.

Conclusion

For most emerging brands, OEM is the lower-risk starting point. Before signing, check the MOQ for every component, define formula access, exclusivity, similarity, and transfer rights, and agree on how changes and failed batches will be handled. A standard-packaging project may be planned around 8-12 weeks, while a custom project may need 4-8 months. In the $180,000 annual cost example, three useful projects cost $60,000 each, compared with $15,000 at 12 projects. In-house formulation is justified only when steady project volume, qualified staff, faster revisions, and valuable formula knowledge support the fixed cost. More information is available in the XUELEI company profile.